Literature DB >> 10729140

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

A Higginbottom1, E R Quinn, C C Kuo, M Flint, L H Wilson, E Bianchi, A Nicosia, P N Monk, J A McKeating, S Levy.   

Abstract

Human CD81 has been previously identified as the putative receptor for the hepatitis C virus envelope glycoprotein E2. The large extracellular loop (LEL) of human CD81 differs in four amino acid residues from that of the African green monkey (AGM), which does not bind E2. We mutated each of the four positions in human CD81 to the corresponding AGM residues and expressed them as soluble fusion LEL proteins in bacteria or as complete membrane proteins in mammalian cells. We found human amino acid 186 to be critical for the interaction with the viral envelope glycoprotein. This residue was also important for binding of certain anti-CD81 monoclonal antibodies. Mutating residues 188 and 196 did not affect E2 or antibody binding. Interestingly, mutation of residue 163 increased both E2 and antibody binding, suggesting that this amino acid contributes to the tertiary structure of CD81 and its ligand-binding ability. These observations have implications for the design of soluble high-affinity molecules that could target the CD81-E2 interaction site(s).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729140      PMCID: PMC111874          DOI: 10.1128/jvi.74.8.3642-3649.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

Review 1.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.

Authors:  D T Fearon; R H Carter
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 2.  The tetraspanin superfamily: molecular facilitators.

Authors:  H T Maecker; S C Todd; S Levy
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

3.  The measurement of relative antibody affinity by ELISA using thiocyanate elution.

Authors:  R A Macdonald; C S Hosking; C L Jones
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

4.  Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82.

Authors:  T Imai; M Kakizaki; M Nishimura; O Yoshie
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.

Authors:  M R Schick; S Levy
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

6.  TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.

Authors:  R Oren; S Takahashi; C Doss; R Levy; S Levy
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

8.  Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes.

Authors:  J M Pawlotsky; F Roudot-Thoraval; P Simmonds; J Mellor; M B Ben Yahia; C André; M C Voisin; L Intrator; E S Zafrani; J Duval; D Dhumeaux
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

9.  CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation.

Authors:  S C Todd; S G Lipps; L Crisa; D R Salomon; C D Tsoukas
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance.

Authors:  I Tachibana; M E Hemler
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  88 in total

1.  Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell line.

Authors:  C T Yeh; H Y Lai; T C Chen; C M Chu; Y F Liaw
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81.

Authors:  Heidi E Drummer; Kirilee A Wilson; Pantelis Poumbourios
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking.

Authors:  Oleg V Kovalenko; Xiuwei Yang; Tatiana V Kolesnikova; Martin E Hemler
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

4.  Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; el-Rashdy M Redwan; Samar Youssef; Moataza H Omran; Fouad Thakeb; Maha el-Demellawy
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 5.  Tetraspanins in viral infections: a fundamental role in viral biology?

Authors:  F Martin; D M Roth; D A Jans; C W Pouton; L J Partridge; P N Monk; G W Moseley
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 6.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.

Authors:  Varadarajan Parthasarathy; Francine Martin; Adrian Higginbottom; Helen Murray; Gregory W Moseley; Robert C Read; Gorakh Mal; Rachel Hulme; Peter N Monk; Lynda J Partridge
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

8.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Authors:  Xiping Zhao; Zhen-Ya Tang; Bettina Klumpp; Guido Wolff-Vorbeck; Heidi Barth; Shoshana Levy; Fritz von Weizsäcker; Hubert E Blum; Thomas F Baumert
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

9.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry().

Authors:  Haiqing Jiang; Jizhen Wang; Balaji Manicassamy; Santhakumar Manicassamy; Michael Caffrey; Lijun Rong
Journal:  Virol Sin       Date:  2009-04       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.